Home
Subscription
October 2024 issue
September 2024 issue
August 2024 issue
July 2024 issue
June 2024 issue
May 2024 issue
April 2024 issue
April 1, 2024 issue
March 2024 issue
February 2024 issue
January 2024 issue
BACK ISSUES
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2013 Issues
December 2013 Issue
• New Drug Review: Dabrafenib mesylate (Tafinlar)
• New Drug Review: Trametinib dimethyl sulfoxide (Mekinist)
• Index for 2013
November 2013 Issue
• Feature - Inspiration!
• New Drug Review: Crofelemer (Fulyzaq)
October 2013 Issue
• Feature - Obtaining Health Insurance that Isn't Understood Using a System that Isn't Working - And the Situation Will Get Worse if there is not Compromise!
• New Drug Review: Ospemifene (Osphena)
September 2013 Issue
• Feature - Boards of Pharmacy Should Discontinue Issuing Licenses to Pharmacies that Sell Tobacco Products and to Pharmacies that are in Facilities that Sell Tobacco Products
• New Drug Review: Vilanterol trifenatate/fluticasone furoate (Breo Ellipta)
August 2013 Issue
• Feature - Mail-order Pharmacy Threatens the Role of Pharmacists as Health Professionals
• New Drug Review: Dimethyl fumarate (Tecfidera)
July 2013 Issue
• Feature - Pharmacists Be On Guard! For the Protection of Your Patients and Yourselves
• New Drug Review: Lorcaserin (Belviq)
June 2013 Issue
• Feature - Walgreens Challenges CVS in the Race to the Bottom - But No Individuals are Accountable!
• New Drug Review: Alogliptin benzoate (Nesina)
May 2013 Issue
• Feature - Pfizer's Viagra Promotion Puts Patients at Risk and is an Insult to Local Pharmacists
• New Drug Review: Canagliflozin (Invokana)
April 2013 Issue
• Feature - Pharmacy as a Career Choice? YES!
• New Drug Review: Apixaban (Eliquis)
March 2013 Issue
• Feature - "I Quit CVS Today"
• New Drug Review: Linaclotide (Linzess)
February 2013 Issue
• Feature - Express Scripts Almost Discovers Conscience - But Fails to Do So!
• New Drug Review: Teriflunomide (Aubagio)
January 2013 Issue
• Feature - The APhA and ASHP Should Merge!
• New Drug Review: Aclidinium bromide (Tudorza Pressair)
• New Therapeutic Agents Marketed in the United States in 2012 (Table)
| |
